Pfizer, Govt in talks to bring COVID vaccine in India
New Delhi: To bring Pfizer-BioNTech Covid-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer Inc.In a statement on Monday, Pfizer spokesperson said, "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-BioNTech Covid-19 vaccine for use in the country. We are unable to divulge further details at this moment."...
Login or Register to read the full article
New Delhi: To bring Pfizer-BioNTech Covid-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer Inc.
In a statement on Monday, Pfizer spokesperson said, "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-BioNTech Covid-19 vaccine for use in the country. We are unable to divulge further details at this moment." On state procurement tenders, the US vaccine maker said it will supply vaccines only to central governments.
"Pfizer will supply Covid-19 vaccine only to central governments and supra-national organisations for deployment in national immunization programs. Allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidance," it said.
Pfizer said that the development, manufacturing, distribution and storage of complex innovative products, including the mRNA technology, requires globally-optimized supply chains.
"Since the beginning of this pandemic, Pfizer's priority has been to ensure rapid manufacturing and deployment of the Covid-19 vaccine to cater to the current emergency response scenario. We have a robust supply chain currently in place with established capabilities - one each in the US and one in Europe - that can quickly manufacture and deploy the vaccine for use across the world," the spokesperson said.
Pfizer and BioNTech have set a target to deliver over 2.5 billion vaccine doses in 2021. This includes expanding the manufacturing capabilities and increasing the supplier base for key materials to the supply chain, said the company official.
Read also: UP in talks with Pfizer, Dr Reddys, others for buying COVID vaccines for USD 1.36 billion
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd